Revenue
2011
2012
2014
2021
2022
2023
2024
2025
| 2025 | 2024 | 2023 | 2022 | 2021 | 2014 · Dec 31 | 2014 · Jun 30 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $10,050 | $69,400 | $154,647 | — | — | $0 | $0 |
| Gross profit | $0 | $0 | $0 | $10,050 | $41,950 | $32,836 | — | — | — | — |
| Research & development | $267,013 | $0 | — | — | — | $151,245 | — | — | — | — |
| Operating expenses | $918,174 | $65,739 | $225,457 | $46,495 | $245,731 | $2.5M | $22,310 | $47,905 | $36,927 | $88,239 |
| Operating income | −$918,174 | −$65,739 | −$225,457 | −$36,445 | −$203,781 | — | −$22,310 | −$47,905 | — | — |
| EBITDAderived | — | — | −$225,457 | −$36,445 | — | — | — | — | — | — |
| Net income | −$1.1M | −$108,091 | −$267,852 | −$106,730 | −$346,826 | −$2.4M | −$24,287 | −$49,174 | −$37,802 | −$88,364 |
| Basic EPSper diluted share | -$0.01 | $0.00 | $0.00 | $0.00 | -$0.01 | — | — | — | — | — |
| Diluted EPSper diluted share | — | — | — | — | -$0.01 | — | — | — | — | — |